Condition: Nociceptive Pain · Neuropathic Pain · Sponsor: ETH Zurich
The pAIn-sense study aims to revolutionize the monitoring and treatment of chronic pain, a major health concern that significantly impacts psychological well-being and quality of life. Traditional approaches to pain management face challenges like unspecific drug use and high healthcare costs, and they often leave patients dissatisfied. PAIn-sense aims at comprehensively understanding pain from both physical and emotional perspectives. To accomplish this, the study will employ advanced Artificial Intelligence (AI) techniques and wearable sensing technology. The study aims to monitor patients continuously, during both day and night activities, to gather a multidimensional set of data on their physiological, psychosocial, and pain conditions.
This description comes directly from the study's public registry record.
Andrea Cimolato, PhD · 772466601 · andrea.cimolato@gmail.com
Noemi Gozzi · noemi.gozzi@gmail.com
Always discuss trial participation with your own doctor first.
| Unita Spinale ASL | Pietra Ligure, Savona, Italy | Recruiting |
| Neuroengineering Lab | Zurich, Canton of Zurich, Switzerland | Recruiting |
| Balgrist University Hospital | Zurich, Canton of Zurich, Switzerland | Recruiting |
| CRR Suva (Clinique romande de réadaptation) | Sion, Valais, Switzerland | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06044584